BIOMAT Database Logo BIOMAT Database Logo

Synthesis of six analogues and their two fragments related to L-alpha-hydroxyisovaleryl-Leu-Val-Phe-OMe as renin inhibitor. 1981

T Abiko, and I Onodera, and H Sekino

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T Abiko, and I Onodera, and H Sekino
N-(alpha-Hydroxyalkanoyl) derivatives of Leu-Val-Phe-OCH3 as inhibitors of renin.
June 1980, Journal of medicinal chemistry,
T Abiko, and I Onodera, and H Sekino
Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
October 2006, Bioorganic chemistry,
T Abiko, and I Onodera, and H Sekino
Conformational studies of chemotactic HCO-Met-Leu-Phe-OMe analogues.
December 1995, Amino acids,
T Abiko, and I Onodera, and H Sekino
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
June 2012, Journal of peptide science : an official publication of the European Peptide Society,
T Abiko, and I Onodera, and H Sekino
Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
September 2007, Amino acids,
T Abiko, and I Onodera, and H Sekino
Synthesis of 3'-triazoyl-dinucleotides as precursors of stable Phe-tRNA(Phe) and Leu-tRNA(Leu) analogues.
August 2014, Bioorganic & medicinal chemistry letters,
T Abiko, and I Onodera, and H Sekino
Synthesis, and crystal and molecular structure of the 3(10)-helical alpha,beta-dehydro pentapeptide Boc-Leu-Phe-Ala-delta Phe-Leu-OMe.
February 1995, Biopolymers,
T Abiko, and I Onodera, and H Sekino
Synthesis, crystal structure, and molecular conformation of N-Boc-L-Phe-dehydro-Leu-L-Val-OCH3.
January 1990, Biopolymers,
T Abiko, and I Onodera, and H Sekino
Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization.
December 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
T Abiko, and I Onodera, and H Sekino
Structure and conformations of two cycloisomeric hexapeptides: cyclo(L-Leu-L-Phe-Gly-D-Phe-L-Leu-Gly-) trihydrate and cyclo(L-Phe-L-Leu-Gly-D-Leu-L-Phe-Gly-) trihydrate.
April 1990, Acta crystallographica. Section B, Structural science,
Copied contents to your clipboard!